Filing Details

Accession Number:
0001209191-17-006519
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-31 20:31:18
Reporting Period:
2017-01-27
Filing Date:
2017-01-31
Accepted Time:
2017-01-31 20:31:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 264106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638380 Shane Ward C/O Versartis, Inc.
4200 Bohannon Dr., Suite 250
Menlo Park CA 94025
Svp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-27 20,600 $0.00 39,865 No 4 A Direct
Common Stock Disposition 2017-01-30 1,474 $13.85 38,391 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2017-01-27 46,200 $0.00 46,200 $14.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
46,200 2027-01-26 No 4 A Direct
Footnotes
  1. Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the award vest on each of the first, second, third and fourth anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
  2. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
  3. 1/48th of the shares subject to the option become exercisable monthly measured from the date of grant.